688606 Hangzhou Alltest Biotech
- 57.45
- -1.77-2.99%
Hangzhou Alltest Biotech News
Hangzhou Aotai Biotechnology Co., Ltd. 2024 Restricted Stock Incentive Plan (Draft) Summary Announcement
Legal Opinion of Shanghai Lifeng Law Firm on Hangzhou Aotai Biotechnology Co., Ltd. 2024 Restricted Stock Incentive Plan (Draft)
Inspection opinion of the board of supervisors of Hangzhou Aotai Biotechnology Co., Ltd. on the 2024 Restricted Stock Incentive Plan (Draft)
Hangzhou Aotai Biotechnology Co., Ltd. awarded the list of incentive recipients for the first time in the 2024 Restricted Stock Incentive Plan
Hangzhou Aotai Biotechnology Co., Ltd. 2024 Restricted Stock Incentive Plan (Draft)
2023 Profit Distribution Plan Announcement
Shareholder dividend return plan for the next three years (2024-2026)
Announcement on the listing and circulation of part of the initial public offering of restricted shares
Announcement on the implementation results of share repurchase
Announcement on the repurchase ratio of the company\'s shares through centralized bidding transactions reaching 1% of the total shares and the progress of the repurchase
Announcement on the progress of repurchasing the company\'s shares through centralized bidding transactions
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement of Hangzhou Aotai Biotechnology Co., Ltd. on the first repurchase of company shares through centralized bidding transactions
Announcement of Hangzhou Aotai Biotechnology Co., Ltd. on the results of the 2022 restricted stock incentive plan granting the first vesting period for the first time
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
The repurchase report of Hangzhou Aotai Biotechnology Co., Ltd. on the repurchase of the company\'s shares through centralized bidding
Announcement of Hangzhou Aotai Biotechnology Co., Ltd. on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions in the share repurchase
Announcement of Hangzhou Aotai Biotechnology Co., Ltd. on the 2022 Restricted Stock Incentive Plan to grant the first vesting period for the first time and to meet the vesting conditions
Analysis
Price Target
No Data
